REQUEST A DEMO
Total
USD $0.00
Search more companies

Qualitas Pharma Sdn. Bhd. (Malaysia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Pharmacies and Drug Stores
Full name: Qualitas Pharma Sdn. Bhd. Profile Updated: August 31, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Qualitas Pharma Sdn. Bhd. is an enterprise in Malaysia, with the main office in Petaling Jaya. The enterprise operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The company was established on February 27, 1981. From the latest financial highlights, Qualitas Pharma Sdn. Bhd. reported a net sales revenue drop of 29.98% in 2022. Its total assets grew by 27.05% over the same period. The net profit margin of Qualitas Pharma Sdn. Bhd. decreased by 0.78% in 2022.

Headquarters
No.20 & 22 Jalan Pjs 7/17, Bandar Sunway
Petaling Jaya; Selangor; Postal Code: 46150

Contact Details: Purchase the Qualitas Pharma Sdn. Bhd. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Qualitas Pharma Sdn. Bhd. report to view the information.
Registered Capital:
Purchase the Qualitas Pharma Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Qualitas Pharma Sdn. Bhd. report to view the information.
Incorporation Date:
February 27, 1981
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Qualitas Pharma Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
-29.98%
Total operating revenue
-29.98%
Operating profit (EBIT)
-35.91%
EBITDA
-33.32%
Net Profit (Loss) for the Period
-36.07%
Total assets
27.05%
Total equity
20.61%
Operating Profit Margin (ROS)
-1.02%
Net Profit Margin
-0.78%
Return on Equity (ROE)
-15.14%
Debt to Equity Ratio
-2.96%
Quick Ratio
-0.06%
Cash Ratio
-0.03%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?